Patents Assigned to NEOGENIS LABS, INC.
  • Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
    Patent number: 10342822
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: July 9, 2019
    Assignees: Board of Regents of the University of Texas System, Neogenis Labs, Inc.
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
    Patent number: 9821006
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: November 21, 2017
    Assignees: Board of Regents of the University of Texas System, Neogenis Labs, Inc.
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
    Patent number: 9241999
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: January 26, 2016
    Assignees: Board of Regents of the University of Texas System, Neogenis Labs, Inc.
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Nitrite formulations and their use as nitric oxide prodrugs
    Patent number: 9119823
    Abstract: Compositions comprising from about 40 weight parts to about 1000 weight parts of a botanical nitrate source; from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; and from about 4 weight parts to about 100 weight parts of a nitrite salt. Use of said composition in methods of reducing triglycerides or reducing C-reactive protein levels are also provided.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: September 1, 2015
    Assignees: Board of Regents, The University of Texas System, Neogenis Labs, Inc.
    Inventors: Nathan S. Bryan, Janet Zand
  • Nitrite formulations and their use as nitric oxide prodrugs
    Patent number: 8962038
    Abstract: Compositions comprising from about 40 weight parts to about 1000 weight parts of a botanical nitrate source; from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; and from about 4 weight parts to about 100 weight parts of a nitrite salt. Use of the composition in methods of reducing triglycerides or reducing C-reactive protein levels are also provided.
    Type: Grant
    Filed: November 5, 2012
    Date of Patent: February 24, 2015
    Assignees: Board of Regents, The University of Texas System, Neogenis Labs, Inc.
    Inventors: Nathan S. Bryan, Janet Zand
  • Method of Producing Physiological and Therapeutic Levels of Nitric Oxide Through an Oral Delivery System
    Publication number: 20130071371
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Application
    Filed: August 17, 2012
    Publication date: March 21, 2013
    Applicants: NEOGENIS LABS, INC., BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Nathan S. Bryan, Jose G. Rocca